The page is the record's research on the issuer — no analyst, no rating, no view.

# Starling Oncology, Inc. (NASDAQ: STLN) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Starling Oncology, Inc., listed on NASDAQ under the ticker STLN, with ISIN US68236X1000. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 8011 Services-Offices & Clinics of Doctors of Medicine, and the jurisdiction is United States, Delaware. The issuer is listed and not halted.

## The disclosure read

The record holds 95 filings in the twelve months to 2026-11-08, across 57 filing days. The median gap between filing days is 3.0 days. The latest filing is dated 2026-11-06, two days before the record date, and is a results filing. Over the same window, the exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days, across 4359 issuers. The sector median is 36 filings, a cadence gap of 6.5 days and a latency of 32 days, across 15 issuers. The issuer's 95 filings are above the exchange median and above the sector median.

## Auditor

The auditor of record is BDO USA, P.C., located in Costa Mesa, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is clear: listed, not halted.

## Orderability

The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.

## Coverage

No research houses were found on the issuer's own investor-relations page; the count is 0.

## Open research

No openly published research notes were found; the count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer's years sealed in the record are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001799191.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/STLN (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1799191/000179919126000007/toi-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/STLN (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/STLN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
